A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical mode (Q43935449)
Jump to navigation
Jump to search
scientific article published in April 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical mode |
scientific article published in April 2002 |
Statements
1 reference
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical mode (English)
1 reference
Garret J Etgen
1 reference
Brian A Oldham
1 reference
William T Johnson
1 reference
Carol L Broderick
1 reference
Chahrzad R Montrose
1 reference
Joseph T Brozinick
1 reference
Elizabeth A Misener
1 reference
James S Bean
1 reference
William R Bensch
1 reference
Dawn A Brooks
1 reference
Anthony J Shuker
1 reference
Christopher J Rito
1 reference
James R McCarthy
1 reference
Robert J Ardecky
1 reference
John S Tyhonas
1 reference
Sharon L Dana
1 reference
James M Bilakovics
1 reference
James R Paterniti
1 reference
Kathleen M Ogilvie
1 reference
Sha Liu
1 reference
Raymond F Kauffman
1 reference
1 April 2002
1 reference
Identifiers
1 reference